Friendships fracture and emotions run high as secrets, surprises, and concern ripple through Fairmont Crest on Beyond the ...
Could guts save your butt? A new study reports that bacteria found in the intestines of Japanese tree frogs show remarkable promise in treating colorectal cancer. A research team from the Japan ...
A Stanford-led team has replaced toxic pre-transplant chemotherapy with a targeted antibody, allowing children with Fanconi anemia to receive stem cell transplants safely. The antibody, briquilimab, ...
After upstaging Merck & Co.’s Keytruda as a monotherapy for patients with first-line non-small cell lung cancer (NSCLC) in China, Akeso and Summit Therapeutics’ ivonescimab has shown it can delay ...
The “Control” singer—who in 2024 shared her diagnoses with lupus and a rare T-cell lymphoproliferative disorder, an umbrella term for diseases related to the overproduction of white blood cells—gave ...
The USB, or Universal Serial Bus, is a common type of connector or port that has been an integral part of our lives for many years. Most computing devices or peripherals we use, like our keyboards and ...
Background: Central venous (CV) ports are extensively employed for the administration of chemotherapy in cancer patients owing to their safety and reliability. The rupture of a CV port catheter is an ...
Researchers at The City College of New York have linked chemotherapy treatment to lasting cognitive changes in rats—potentially shedding light, for the first time, on cognitive problems some cancer ...
Neoadjuvant nivolumab plus chemotherapy significantly improved pathological complete response and event-free survival in patients with resectable non–small-cell lung cancer (NSCLC) in a phase 3 trial.
Treatment with pembrolizumab and the antibody-drug conjugate (ADC) sacituzumab govitecan improved progression-free survival (PFS) in patients with PD-L1-positive locally advanced or metastatic ...
Portal Access, an oncology-focused medical device startup, closed a $7 million Series A financing round. The company said that more than 80% of the round was led by U.S. physician investors, including ...
BUFFALO, N.Y. — Pancreatic cancer is one of the most difficult cancers to treat — and the deadliest. Fewer than 10% of patients with advanced pancreatic cancer live beyond five years. A few factors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback